“Bahrain Pharmaceuticals & Healthcare Report Q3 2010″ now available at Fast Market Research

"Bahrain Pharmaceuticals & Healthcare Report Q3 2010" now available at Fast Market Research
Fast Market Research recommends "Bahrain Pharmaceuticals & Healthcare Report Q3 2010" from Business Monitor International, now available

A population of just 738,000 limits the overall pharmaceutical market in Bahrain. In 2009 Bahrain's pharmaceutical market was worth just BHD43mn (US$112mn) but this is expected to reach BHD54mn (US$142mn) in 2014. However, BMI expects health spending in Bahrain to increase at a far faster rate, expanding from BHD206mn (US$541mn) in 2009 to BHD486mn (US$1.28bn) by 2014, representing a US dollar compound annual growth rate (CAGR) of 18.8%. An expanding population, increased consumption and the growing cost of medical imports will help drive the growth. The latter is especially significant as Bahrain has a very limited manufacturing capacity and imports almost all of its pharmaceutical products, a practice eased by various free trade agreements.
However, the Gulf Cooperation Council (GCC) announced that it had suspended free trade talks with the European Union as the two were unable to converge on several key points. The negotiations have been postponed indefinitely because of disagreements on subsidies in the petrochemicals sector as well as foreign equity stakes. The announcement by the GCC is more likely a sign of posturing rather than abandonment, although there is little indication of when negotiations may resume. There is much scepticism on the plausibility of a similar deal on an India-GCC FTA, which has been conspicuously silent. An India-GCC agreement may go the way of the EU-GCC FTA negotiations for similar reasons. Conversely, the Bahrain Chamber of Commerce and Industry signed a memorandum of understanding (MoU) with Pakistan's Rawalpindi Chamber of Commerce and Industry in March 2010 to boost trade between the countries, which could include significant room for pharmaceutical trade. In any case, pharmaceutical imports will continue to rise from US$77.4mn in 2009 to US$111.5mn by 2014, representing a CAGR of 7.6% in US dollar terms.
Healthcare developments in Bahrain in recent months saw the BHD3.4mn (US$9mn) Nuwaidrat health centre open in north-east Bahrain, in addition to four additional centres to be constructed in the near-term. Saudi Arabia will be spending SAR1bn (US$266.16mn) on a medical city in Bahrain affiliated with the Arabian Gulf University. Meanwhile, the Kuwaiti government has committed a considerably smaller sum of BHD2mn (US$5.28mn) for a healthcare facility in Barbar due to be completed by the end of 2011.
Such investments have helped Bahrain generate some impressive health indicators. Bahrain recently became the first Arab country to have its primary healthcare facilities recognised as world-class by an international accreditation body. The quality of Bahrain's healthcare sector corroborated by Accreditation Canada, which certified the Salmaniya Medical Complex, a psychiatric hospital and 22 primary healthcare centres in the country. Meanwhile, the World Health Organisation (WHO) selected Bahrain as a model country in its monitoring and implementation of international health regulations. Bahrain was also rated the best country in the Middle East for maternal healthcare, as well as the socio-economic and political status of women by Save the Children in 2010.
For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/71626_bahrain_pharmaceuticals ...
Partial Table of Contents:
Executive Summary
SWOT Analysis
- Bahrain Pharmaceuticals And Healthcare Industry SWOT
- Bahrain Political SWOT
- Bahrain Economic SWOT
- Bahrain Business Environment SWOT
Pharmaceutical Business Environment Ratings
- Table: Middle East And Africa - Regional Pharmaceutical Business Environment Ratings For Q310
- Limits of Potential Returns
- Risks to Realisation of Returns
Bahrain - Market Summary
Regulatory Regime
- Recent Regulatory Developments
- GCC Healthcare Collaboration
- Intellectual Property Developments
- Pricing and Reimbursement Regime
- Regional Price Harmonisation
- Free Trade Agreement with the US
- Other Free Trade Agreements
Industry Developments
- Epidemiology
- Table: Leading Causes Of Death In Bahrain, 2008
- HIV/AIDS
- Healthcare Sector
- Primary, Secondary and Tertiary Healthcare
- Health Insurance
- Table: National Health Insurance Scheme Breakdown
- Strategic Healthcare Goals
- Table: Further Ministry Of Health Objectives
- Healthcare Sector Investment
- Features Of Dilmunia Health Island
- Pharmaceutical Industry - Regional Outlook
- Pharmaceutical Sector
- Pharmaceutical Retail
- Research and Development
- International Collaboration
- Medical Devices
Industry Forecast Scenario
- Overall Market Forecast
- Key Growth Factors - Industry
- Key Growth Factors - Macroeconomic
- Table: Bahrain - Economic Activity, 2007-2014
- Prescription Market Forecast
- Patented Product Market Forecast
- Generic Drug Market Forecast
- OTC Medicine Market Forecast
- Pharmaceutical Trade Forecast
- Medical Device Market Forecast
- Other Healthcare Data Forecasts
- Key Risks to BMI's Forecast Scenario
Competitive Landscape
Company Monitor
- Indigenous Companies
- Al-Jishi Corporation
- Bahrain Industrial Pharmaceutical Co (Bidapharm)
- Behzad Medical Establishment
- Yousuf Mahmood Husain Company
- Multinational Companies
- GlaxoSmithKline (GSK)
- Novartis
- Johnson & Johnson (J&J)
- Merck & Co
- Pfizer
- Sanofi-Aventis
Country Snapshot: Bahrain Demographic Data
-
Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=716 ...
About Business Monitor International
Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets.  BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports.  Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports.  View more research from Business Monitor International at http://www.fastmr.com/catalog/publishers.aspx?pubid=1010
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.